Raymond J. Gonzalez

533 total citations
13 papers, 347 citations indexed

About

Raymond J. Gonzalez is a scholar working on Pharmacology, Cancer Research and Molecular Biology. According to data from OpenAlex, Raymond J. Gonzalez has authored 13 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Raymond J. Gonzalez's work include Drug-Induced Hepatotoxicity and Protection (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Mass Spectrometry Techniques and Applications (2 papers). Raymond J. Gonzalez is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Mass Spectrometry Techniques and Applications (2 papers). Raymond J. Gonzalez collaborates with scholars based in United States, United Kingdom and Australia. Raymond J. Gonzalez's co-authors include Joan B. Tarloff, Kara Pearson, Frank D. Sistare, Warren E. Glaab, Rosalind E. Jenkins, Joanne M. Bowen, Wendy J. Bailey, Kevin Park, Neil French and Christopher E. Goldring and has published in prestigious journals such as Analytical Chemistry, Toxicological Sciences and Chemical Research in Toxicology.

In The Last Decade

Raymond J. Gonzalez

12 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond J. Gonzalez United States 7 107 69 49 41 34 13 347
Umesh Hanumegowda United States 12 164 1.5× 50 0.7× 40 0.8× 36 0.9× 42 1.2× 22 394
Masato Ooka United States 14 228 2.1× 33 0.5× 62 1.3× 32 0.8× 76 2.2× 24 410
Marije Niemeijer Netherlands 10 168 1.6× 52 0.8× 31 0.6× 58 1.4× 25 0.7× 19 340
Tracy Walker United Kingdom 9 171 1.6× 55 0.8× 78 1.6× 23 0.6× 55 1.6× 11 397
Amina M. Medhat Egypt 13 168 1.6× 24 0.3× 19 0.4× 76 1.9× 33 1.0× 27 421
Sarinj Fattah Ireland 10 160 1.5× 71 1.0× 46 0.9× 25 0.6× 171 5.0× 17 510
Katharina R. Beck Switzerland 15 185 1.7× 64 0.9× 22 0.4× 40 1.0× 41 1.2× 22 539
Shuanghui Luo United States 13 127 1.2× 27 0.4× 19 0.4× 16 0.4× 76 2.2× 16 352
Esther G. van de Kerkhof Netherlands 6 128 1.2× 180 2.6× 99 2.0× 68 1.7× 224 6.6× 8 551
Regina Arantes‐Rodrigues Portugal 14 237 2.2× 16 0.2× 24 0.5× 36 0.9× 54 1.6× 29 485

Countries citing papers authored by Raymond J. Gonzalez

Since Specialization
Citations

This map shows the geographic impact of Raymond J. Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond J. Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond J. Gonzalez more than expected).

Fields of papers citing papers by Raymond J. Gonzalez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond J. Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond J. Gonzalez. The network helps show where Raymond J. Gonzalez may publish in the future.

Co-authorship network of co-authors of Raymond J. Gonzalez

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond J. Gonzalez. A scholar is included among the top collaborators of Raymond J. Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond J. Gonzalez. Raymond J. Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fawaz, Maria V., Hubert Josien, Kara Pearson, et al.. (2024). Leveraging High-Resolution Ion Mobility-Mass Spectrometry for Cyclic Peptide Soft Spot Identification. Journal of the American Society for Mass Spectrometry. 35(11). 2596–2607. 3 indexed citations
2.
Forest, Thomas, Kyathanahalli S. Janardhan, Michael A. Napolitano, et al.. (2024). Automated anomaly detection in histology images using deep learning. 21–21.
3.
Fawaz, Maria V., et al.. (2024). Rapid and Definitive Identification of Cyclic Peptide Soft Spots by Isotope-Labeled Reductive Dimethylation and Mass Spectrometry Fragmentation. Analytical Chemistry. 96(19). 7756–7762. 2 indexed citations
4.
Vlasáková, Kateřina, Wendy J. Bailey, Shetal Patel, et al.. (2022). Universal Accessible Biomarkers of Drug-Induced Tissue Injury and Systemic Inflammation in Rat: Performance Assessment of TIMP-1, A2M, AGP, NGAL, and Albumin. Toxicological Sciences. 187(2). 219–233. 5 indexed citations
5.
Bowen, Joanne M., Kara Pearson, Raymond J. Gonzalez, et al.. (2021). The application of cytokeratin-18 as a biomarker for drug-induced liver injury. Archives of Toxicology. 95(11). 3435–3448. 32 indexed citations
6.
Xu, Qiuwei, Liping Liu, Amy G. Aslamkhan, et al.. (2019). Can Galactose Be Converted to Glucose in HepG2 Cells? Improving the in Vitro Mitochondrial Toxicity Assay for the Assessment of Drug Induced Liver Injury. Chemical Research in Toxicology. 32(8). 1528–1544. 15 indexed citations
7.
Li, Yutai, Raymond Evers, Michael J. Hafey, et al.. (2019). Use of a Bile Salt Export Pump Knockdown Rat Susceptibility Model to Interrogate Mechanism of Drug-Induced Liver Toxicity. Toxicological Sciences. 170(1). 180–198. 7 indexed citations
8.
Gonzalez, Raymond J., Shu-An Lin, Bohumil Bednář, et al.. (2017). Vascular Imaging of Matrix Metalloproteinase Activity as an Informative Preclinical Biomarker of Drug-induced Vascular Injury. Toxicologic Pathology. 45(5). 633–648. 4 indexed citations
9.
Lin, Shu-An, Brett Connolly, Raymond J. Gonzalez, et al.. (2015). Optical Imaging Biomarkers of Drug-Induced Vascular Injury. Molecular Imaging. 14(1). 1–10. 4 indexed citations
10.
Mikaelian, Igor, Mark J. Cameron, Deidre A. Dalmas, et al.. (2014). Nonclinical Safety Biomarkers of Drug-induced Vascular Injury. Toxicologic Pathology. 42(4). 635–657. 25 indexed citations
11.
Bailey, Wendy J., Dan Holder, Hima Patel, et al.. (2012). A Performance Evaluation of Three Drug-Induced Liver Injury Biomarkers in the Rat: Alpha-Glutathione S-Transferase, Arginase 1, and 4-Hydroxyphenyl-Pyruvate Dioxygenase. Toxicological Sciences. 130(2). 229–244. 38 indexed citations
12.
Gonzalez, Raymond J. & Joan B. Tarloff. (2004). Expression and activities of several drug-metabolizing enzymes in LLC-PK1 cells. Toxicology in Vitro. 18(6). 887–894. 9 indexed citations
13.
Gonzalez, Raymond J. & Joan B. Tarloff. (2001). Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicology in Vitro. 15(3). 257–259. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026